Drug Repurposing for the Treatment of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the accumulation of immature myeloid progenitor cells in the bone marrow, compromising of normal blood cell production and ultimately resulting in bone marrow failure. With a 20% overall survival rate at 5 years and 50% in the...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Frontiers Media S.A.
2017-11-01
|
| Cyfres: | Frontiers in Medicine |
| Pynciau: | |
| Mynediad Ar-lein: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00211/full |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|